Cynvenio Raises Capital, Enters Into Pact With Cancer Patient Exchange Firm
Cynvenio Biosystems has raised $35.5 million in second-round private equity funding and has struck an agreement with another company to help place its patients into clinical trials. The funding for the Westlake Village, Calif.-based Cynvenio came from several venture capital funds, but most notably from Livzon Pharmaceutical Group, Inc., a Chinese-based drug company, which is […]
This content is exclusive to Lab Industry Report subscribers
Start a Free Triall for immediate access to this article and our entire archive of over 20 years of LIR reports.